Berberine ameliorates septic cardiomyopathy through protecting mitochondria and upregulating Notch1 signaling in cardiomyocytes
IntroductionSeptic cardiomyopathy (SCM) arises as a consequence of sepsis-associated cardiovascular dysfunction, for which there is currently no specific targeted therapy available. Previous studies have demonstrated the beneficial therapeutic effect of berberine (BBR) on SCM; however, the underlyin...
Saved in:
Main Authors: | Qi Shen (Author), Yufan Yuan (Author), Zelin Li (Author), Ying Ling (Author), Jian Wang (Author), Mingjing Gao (Author), Peng Wang (Author), Mengli Li (Author), Lizhong Lai (Author), Jinlan Jin (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2024-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Berberine attenuates septic cardiomyopathy by inhibiting TLR4/NF-κB signalling in rats
by: Huiqi Chen, et al.
Published: (2021) -
Salidroside Ameliorates Cardiomyocyte Hypertrophy by Upregulating Peroxisome Proliferator-Activated Receptor-α
by: Hui Gao, et al.
Published: (2022) -
Mogroside IIe Ameliorates Cardiomyopathy by Suppressing Cardiomyocyte Apoptosis in a Type 2 Diabetic Model
by: Xin Cai, et al.
Published: (2021) -
Emerging roles of microRNAs in septic cardiomyopathy
by: Mingyan Wu, et al.
Published: (2023) -
Diminazene aceturate mitigates cardiomyopathy by interfering with renin-angiotensin system in a septic rat model
by: Zhaoqing Lu, et al.
Published: (2022)